News
The Big Reason ImmunoGen, Inc. Shed 24% of Its Value in October
Shares of ImmunoGen (NASDAQ: IMGN), a small-cap biotech company focused on the development of antibody-drug conjugates for the treatment of cancer, plunged 24% in October, according to data from....
4 Things ConocoPhillips' CFO Wants You to Know About Its Stunning Transformation
ConocoPhillips (NYSE: COP) recently reported surprisingly strong third-quarter results, easily overcoming the impact from Hurricane Harvey. Not only was production at the high end of its guidance....
DALET : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL
Paris, le 07 novembre 2017
DALET S.A.
Siège Social : 16 rue Rivay - 92 300 LEVALLOIS PERRET
RCS NANTERRE 378 017 016
Déclaration au titre de l'article 223-16 du règlement général de l'AMF
Au....
Surprise! iPhone X May Be More -- Not Less -- Profitable Than iPhone 8
A couple months ago, Susquehanna estimated that Apple's (NASDAQ: AAPL) iPhone X would have a bill of materials (BOM) of $581, which suggested that the hardware margin on the 10th-anniversary....
Surprise! iPhone X May Be More -- Not Less -- Profitable Than iPhone 8
A couple months ago, Susquehanna estimated that Apple's (NASDAQ: AAPL) iPhone X would have a bill of materials (BOM) of $581, which suggested that the hardware margin on the 10th-anniversary....
Surprise! iPhone X May Be More -- Not Less -- Profitable Than iPhone 8
A couple months ago, Susquehanna estimated that Apple's (NASDAQ: AAPL) iPhone X would have a bill of materials (BOM) of $581, which suggested that the hardware margin on the 10th-anniversary....
Surprise! iPhone X May Be More -- Not Less -- Profitable Than iPhone 8
A couple months ago, Susquehanna estimated that Apple's (NASDAQ: AAPL) iPhone X would have a bill of materials (BOM) of $581, which suggested that the hardware margin on the 10th-anniversary....
Here's Why Teligent Stock Was Cut Nearly in Half Today
Shares of specialty generic pharmaceutical manufacturer Teligent (NASDAQ: TLGT) dropped as much as 46% today after investors digested the company's third-quarter 2017 results. Operations appeared....
Why Extended Stay America Inc Stock Tumbled Today
Shares of Extended Stay America Inc (NYSE: STAY) were getting evicted by investors today after the discount hotel chain posted worse results than expected in its third-quarter report and lowered....
Why Shares of TrueCar Are Down Sharply Today
Shares of online car-shopping service TrueCar (NASDAQ: TRUE) were down sharply on Tuesday, after the company posted a wider third-quarter loss and scaled back its full-year guidance.As of noon....
Eldorado Gold Corp. Plunged 40.9% in October: What's Next?
It was a month investors in Eldorado Gold (NYSE: EGO) would want to forget in a jiffy. Shares of the junior gold miner plunged 40.9% in October, extending its year-to-date losses to a whopping 61%....
Why Celldex Therapeutics Jumped Higher Today
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is up 16% at 12:04 p.m. EST after releasing third-quarter earnings this morning, although the stock move likely has more to do with data released in....
HERIGE : CHIFFRE D'AFFAIRES AU 30 SEPTEMBRE 2017 : 402,2 M EUR
Poursuite de la croissance au troisième trimestre : 3,6%
(à périmètre comparable)
IFRS – M€
Chiffre d'affaires consolidé
2017(1)
2016 (2) IFRS 5
Var. % 2017 vs 2016 IFRS 5
WAVESTONE : Declaration according to article 223-16 (AMF)
In accordance with article L233-8 of commercial law, Wavestone informs its shareholders that as of October 2017, its capital was composed of 4 966 882 shares representing 7 814 510 voting....
HERIGE : INFORMATION MENSUELLE RELATIVE AUX DROITS DE VOTE AU 31 OCTOBRE 2017
INFORMATION MENSUELLE RELATIVE AUX DROITS DE VOTE
ART. L233-8-II du code de commerce et ART 223-16 du règlement général de l'AMF
Nature des titres : ISIN FR0000066540
DATE D'ARRETE
TESSI : 2017 nine-month turnover up 6.6% at EUR 319.9 million
Consolidated turnover (1 January – 30 September)
€m – non-audited
2017
2016
Change
H1 turnover
219.4
203.1
+8.0%
Q3 turnover
100.5
97.2
+3.4%
Total
HERIGE : TURNOVER AT 30 SEPTEMBER 2017: EUR 402.2 MILLION
Continued growth in the third quarter: 3.6%
(like-for-like)
IFRS – € million
Consolidated turnover
2017(1)
2016(2) IFRS 5
Change % 2017 vs 2016 IFRS....
A.S.T. GROUPE : AST GROUPE : Chiffre d'affaires 9 mois 2017 = 108.2 M EUR
Communiqué de presse
A Décines-Charpieu, le 7 novembre 2017
Activité à 9 mois de 108,2 M€ (+29,3%)
Croissance organique de +21%
1 300 ventes à fin septembre 2017
En Millions....
TripAdvisor Inc (TRIP) Q3 2017 Earnings Conference Call Transcript
Image source: The Motley Fool.TripAdvisor, Inc. (NASDAQ: TRIP)Q3 2017 Earnings Conference CallNov. 7, 2017, 8:30 a.m. ETOperatorContinue readingSource: Fool.com
Why Shares of Priceline Group Are Tumbling Today
Shares of online travel company Priceline Group (NASDAQ: PCLN) slumped on Tuesday following its third-quarter report. While Priceline beat analyst estimates for both revenue and earnings, the....
Why Shares of Priceline Group Are Tumbling Today
Shares of online travel company Priceline Group (NASDAQ: PCLN) slumped on Tuesday following its third-quarter report. While Priceline beat analyst estimates for both revenue and earnings, the....
Why Shares of Priceline Group Are Tumbling Today
Shares of online travel company Priceline Group (NASDAQ: PCLN) slumped on Tuesday following its third-quarter report. While Priceline beat analyst estimates for both revenue and earnings, the....
Why TripAdvisor Stock Got Torched Today
Tripadvisor Inc (NASDAQ: TRIP) was having another bad trip as the stock tumbled today following an underwhelming third-quarter earnings report. Shares were down 17.9% as of 10:56 a.m. EST.The....
What to Look Out For When Ubiquiti Networks Reports Earnings
Ubiquiti Networks (NASDAQ: UBNT) investors had an interesting ride this fall. After strong earnings in August and robust guidance, the stock climbed to $67, but in September, the company became....
Celldex Therapeutics, Inc.'s Most Important Takeaway From Q3 Isn't a Number
Investors view quarterly updates from clinical-stage biotechs in a very different way than they do for other companies. The bottom line isn't nearly as important for these small biotechs as are....